GammaTile is a Food and Drug Administration (FDA)-licensed device consisting of four
cesium-131 (Cs-131) radiation-emitting seeds in the collagen tile about the postage stamp …

After recent updates to the World Health Organization pathological criteria for diagnosing
and grading diffuse gliomas, all major North American and European neuro-oncology …

Glioblastoma is the most common primary malignant neoplasm of the central nervous
system in adults. Standard of care is resection followed by chemo-radiation therapy. Despite …

The mainstays of radiation therapy include external beam radiation therapy (EBRT) and
internally implanted radiation, or brachytherapy (BT), all with distinct benefits and risks in …

Abstract Background The introduction of Cesium-131 (Cs-131) as a radiation source has led
to a resurgence of brachytherapy for central nervous system (CNS) tumors. The aim of this …

Glioblastoma (GBM) is the most common malignant primary brain tumor in adults. Despite
an established standard of care including surgical resection, radiation therapy, and …

Abstract Purpose of Review The purpose of this review is to discuss a wide variety of novel
therapies recently studied or actively undergoing study in patients with glioblastoma. This …

Purpose Re-irradiation of recurrent glioblastoma (GBM) may delay further recurrence but re-
irradiation increases the risk of radionecrosis (RN). Salvage therapy should focus on …

Abstract GammaTile®(GT Medical Technologies, Tempe, Arizona) is a surgically targeted
radiation source, approved by FDA for brachytherapy in primary and secondary brain …

Radiation is a mainstay of treatment for central nervous system (CNS) tumors.
Brachytherapy involves the placement of a localized/interstitial radiation source into a tumor …